NVO vs. CRWD
NVO (Novo Nordisk A/S) and CRWD (CrowdStrike Holdings, Inc.) are both stocks. NVO operates in Drug Manufacturers - General (Healthcare), while CRWD operates in Software - Infrastructure (Technology). Over the past 5 years, NVO returned 2.92%/yr vs 24.18%/yr for CRWD. At a 0.21 correlation, their price movements are largely independent.
Performance
NVO vs. CRWD - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, NVO achieves a -10.74% return, which is significantly lower than CRWD's 45.66% return.
NVO
- 1D
- -0.18%
- 1M
- -6.80%
- YTD
- -10.74%
- 6M
- -9.50%
- 1Y
- -43.34%
- 3Y*
- -15.59%
- 5Y*
- 2.92%
- 10Y*
- 7.56%
CRWD
- 1D
- -1.26%
- 1M
- 21.37%
- YTD
- 45.66%
- 6M
- 35.27%
- 1Y
- 41.74%
- 3Y*
- 64.60%
- 5Y*
- 24.18%
- 10Y*
- —
NVO vs. CRWD - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|---|
NVO Novo Nordisk A/S | -10.74% | -39.22% | -15.93% | 54.84% | 22.66% | 63.52% | 23.33% | 13.19% |
CRWD CrowdStrike Holdings, Inc. | 45.66% | 37.00% | 34.01% | 142.49% | -48.58% | -3.34% | 324.74% | -21.46% |
Correlation
The correlation between NVO and CRWD is 0.17, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.17 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.18 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.21 |
Correlation (All Time) Calculated using the full available price history since Jun 12, 2019 | 0.21 |
Fundamentals
NVO:
$195.21B
CRWD:
$176.08B
NVO:
DKK 27.42
CRWD:
-$0.02
NVO:
3.85
CRWD:
34.09
NVO:
6.21
CRWD:
38.00
NVO:
DKK 327.80B
CRWD:
$5.09B
NVO:
DKK 268.30B
CRWD:
$3.82B
NVO:
DKK 181.54B
CRWD:
$246.78M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
NVO vs. CRWD — Risk / Return Rank
NVO
CRWD
NVO vs. CRWD - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Novo Nordisk A/S (NVO) and CrowdStrike Holdings, Inc. (CRWD). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| NVO | CRWD | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.76 | ||
| Sortino ratioReturn per unit of downside risk | -2.53 | ||
| Omega ratioGain probability vs. loss probability | 0.85 | 1.19 | -0.34 |
| Calmar ratioReturn relative to maximum drawdown | -0.80 | 1.13 | -1.93 |
| Martin ratioReturn relative to average drawdown | -1.18 | 2.57 | -3.75 |
Loading charts...
Drawdowns
NVO vs. CRWD - Drawdown Comparison
The maximum NVO drawdown since its inception was -74.70%, which is greater than CRWD's maximum drawdown of -67.69%. Use the drawdown chart below to compare losses from any high point for NVO and CRWD.
Loading charts...
Drawdown Indicators
| NVO | CRWD | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -74.70% | -67.69% | -7.01% |
Max Drawdown (1Y)Largest decline over 1 year | -54.34% | -37.18% | -17.16% |
Max Drawdown (3Y)Largest decline over 3 years | -74.70% | -44.44% | -30.26% |
Max Drawdown (5Y)Largest decline over 5 years | -74.70% | -67.69% | -7.01% |
Max Drawdown (10Y)Largest decline over 10 years | -74.70% | — | — |
Current DrawdownCurrent decline from peak | -68.11% | -12.70% | -55.41% |
Average DrawdownAverage peak-to-trough decline | -17.79% | -23.61% | +5.82% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 37.62% | 16.29% | +21.33% |
Volatility
NVO vs. CRWD - Volatility Comparison
The current volatility for Novo Nordisk A/S (NVO) is 10.68%, while CrowdStrike Holdings, Inc. (CRWD) has a volatility of 18.47%. This indicates that NVO experiences smaller price fluctuations and is considered to be less risky than CRWD based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| NVO | CRWD | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 10.68% | 18.47% | -7.79% |
Volatility (6M)Calculated over the trailing 6-month period | 38.04% | 37.66% | +0.38% |
Volatility (1Y)Calculated over the trailing 1-year period | 51.88% | 45.48% | +6.40% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 38.33% | 50.78% | -12.45% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 32.56% | 56.07% | -23.51% |
Dividends
NVO vs. CRWD - Dividend Comparison
NVO's dividend yield for the trailing twelve months is around 4.11%, while CRWD has not paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
CRWD CrowdStrike Holdings, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
NVO Novo Nordisk A/S | 4.11% | 3.31% | 1.68% | 1.00% | 1.20% | 1.35% | 1.87% | 2.14% | 1.45% | 1.52% | 2.87% | 0.92% |
Financials
NVO vs. CRWD - Financials Comparison
This section allows you to compare key financial metrics between Novo Nordisk A/S and CrowdStrike Holdings, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
NVO vs. CRWD - Profitability Comparison
NVO - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Novo Nordisk A/S reported a gross profit of 83.23B and revenue of 96.82B. Therefore, the gross margin over that period was 86.0%.
CRWD - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, CrowdStrike Holdings, Inc. reported a gross profit of 1.04B and revenue of 1.39B. Therefore, the gross margin over that period was 75.3%.
NVO - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Novo Nordisk A/S reported an operating income of 59.62B and revenue of 96.82B, resulting in an operating margin of 61.6%.
CRWD - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, CrowdStrike Holdings, Inc. reported an operating income of -30.60M and revenue of 1.39B, resulting in an operating margin of -2.2%.
NVO - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Novo Nordisk A/S reported a net income of 48.56B and revenue of 96.82B, resulting in a net margin of 50.2%.
CRWD - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, CrowdStrike Holdings, Inc. reported a net income of 45.97M and revenue of 1.39B, resulting in a net margin of 3.3%.
Frequently Asked Questions
NVO and CRWD have a correlation of 0.17, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
CRWD has higher volatility (18.47%) compared to NVO (10.68%). In terms of maximum drawdown, NVO dropped -74.70% vs CRWD's -67.69%.
CRWD currently has the higher Sharpe Ratio (0.92 vs -0.84), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for NVO and CRWD
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer